Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-006440

CHIEF OPERATING OFFICER gave up 801 shares (to pay taxes)

  • CHIEF OPERATING OFFICER acquired 2,727 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2023-04-10 Option exercise +2,727 120,868 D
Tessari Eben CHIEF OPERATING OFFICER 2023-04-10 Shares withheld for taxes −801 $10.71 $8,579 120,067 D
Derivatives
Tessari Eben CHIEF OPERATING OFFICER 2023-04-10 Option exercise · Restricted Share Unit +2,727 8,178 D
Loading xslF345X04/form4-04112023_090449.xml…